RelB regulation of chemokine expression modulates local inflammation

American Journal of Pathology

Volumn 151, Issue 2, 1997, Pages 375-387

  Xia, Yiyang ^a   Pauza, Mary E ^a   Feng, Lili ^a   Lo, David ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE INDUCTION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; CHEMOKINES; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0030762656     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA: Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils, J Exp Med 1990, 178:1493-1500
2. Vaddi K, Newton RC: Regulation of monocyte integrin expression by β-family chemokines, J Immunol 1994, 153:4721-4732
3. Rot A: Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism, Eur J Immunol 1993, 23:303-306
4. Geiser T, Dewald B, Ehrengruber MR, Clark-Lewis I, Baggiolini M: The interleukin-8-related chemotactic cytokines GROα, GROβ, and GROγ activate human neutrophil and basophil leukocytes. J Biol Chem 1993, 268:15419-15424
5. +2] changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. J Leukocyte Biol 1991, 50:279-286
6. Sylvester I, Suffredini AF, Boujoukos AJ, Martich GD, Danner RL, Yoshimura T, Leonard EJ: Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum: effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J Immunol 1993, 151:3292-3298
7. Chaudhuri A, Zbrzenzna V, Polyakova J, Pogo A, Hesselgesser J, Horuk R: Expression of the Duffy antigen in K652 cells: evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994, 269:7835-7838
8. Furie MB, Randolph GJ: Chemokines and tissue injury. Am J Pathol 1995, 146:1287-1301
9. Gilmore TD, Koedood M, Piffat KA, White DW: Rel/NF-κB/lκB proteins and cancer. Oncogene 1997 (in press)
10. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995, 376:176-170
11. Baeuerle PA, Baltimore D: NF-κB: ten years after. Cell 1996, 87:13-20
12. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Gate R, Lo D: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536
13. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA, Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 1995, 80:331-340
14. Baldwin AS Jr: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-681
15. Ryseck RP, Bull P, Takamiya M, Bours V, Siebenlist U, Dobrzanski P, Bravo R: RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B, Mol Cell Biol 1992, 12:674-684
16. Lernbecher T, Kistler B, Wirth T: Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J 1994, 13:4046-4069
17. Grilli M, Chiu JS, Lenardo MJ: NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143: 1-62
18. Baeuerle PA, Henkel T: Function and activation of NK-kappa B in the immune system. Annu Rev Immunol 1994, 12:141-179
19. Widmer U, Manogue KR, Cerami A, Sherry B: Genomic cloning and promoter analysis of macrophage inflammatory protein (MIPJ-2, MIP-1 α, and MIP-1 β, members of the chemokine superfamily of proinflammatory cytokines. J Immunol 1993, 150:4996-5012
20. Beg AA, Sha W, Bronson R, Baltimore D: Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα deficient mice. Genes Dev 1995, 9:2736-2746
21. Lo D, Quill H, Burkly L, Scott B, Palmiter RD, Brinster RL: A recessive defect in lymphocyte or granulocyte function caused by an integrated transgene. Am J Pathol 1992, 141:1237-1246
22. Feng L, Xia Y, Kreisberg JI, Wilson CB: lnterleukin-1α stimulates KC synthesis in rat mesangial cells: glucocorticoids inhibit KC induction by IL-1. Am J Physiol 1994, 266: F713-F722
23. Conrad RE: Induction and collection of peritoneal exudate macrophages. Manual of Macrophage Methodology. Edited by HB Herscowits, HT Holden, JA Bellanti, A Ghaffar, New York. Marcel Dekker, 1981, pp 1-11
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
25. Xia Y, Feng L, Yoshimura T, Wilson CB: LPS-induced MCP-1, IL1β, and TNF-α mRNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol (Renal) 1993, 266: F774-F780
26. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei, Nucleic Acids Res 1983, 11:1475-1489
27. DeKoning J, DiMolfetto L, Reilly C, Wei Q, Havran W, Lo D: T cell development in relB deficient mice: positive selection and acquisition of function do not require thymic medulla. J Immunol 1997, 158:2558-2566
28. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH: Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex, Nature 1996, 383:81-85
29. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation, Curr Opin Immunol 1994, 6:865-873
30. Ito CY, Kazantsev AG, Baldwin AS Jr: Three NF-KB sites in the IKB-α promoter are required for induction of gene expression by TNFα. Nucleic Acids Res 1994, 22:3787-92
31. Sun SC, Ganchi PA, Ballard DW, Greene WC: NF-kappa B controls expression of inhibitor I kappa Bα: evidence for an inducible autoregulatory pathway. Science 1993, 259:1912-1915
32. Dobrzanski P, Ryseck R, Bravo R: Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif, Mol Cell Biol 1993, 13:1572-1582
33. Bours V, Azarenko V, Dejardin E, Siebenlist U: Human RelB (l-Rel) functions as a κB site-dependent transactivating member of the family of Rel-related proteins. Oncogene 1994, 9:1699-1702
34. Lernbecher T, Miller U, Wirth T: Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 1993, 365:767-770
35. Dobrzanski P, Ryseck RP, Bravo R: Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 1995, 10:1003-1007
36. Cheng Q, Cant CA, Moil T, Hofer-Qarbinek R, Wagner E, Birnstiel ML, Bach RH, de Martin R: NF-kappa B subunit-specific regulation of the I kappa B α promoter. J Biol Chem 1994, 269:13551-13557
37. Bombara MP, Webb DL, Conrad P, Marlor CW, Sarr T, Ranges GE, Aune TM, Greve JM, Blue ML: Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines, J Leukocyte Biol 1993, 54:399-406
38. Mauviel A, Teitamo S, Remitz A, Lapiere JC, Ceska M, Baggiolini M, Walz A, Evans CH, Uitto J: Leukoregulin, a T cell-derived cytokine, induces IL-8 gene expression and secretion in human skin fibroblasts: demonstration and secretion in human skin fibroblasts: demonstration of enhanced NF-kappa B binding and NF-kappa Bdriven activity. J Immunol 1992, 149:2969-2976
39. Weih F, Lira SA, Bravo R: Overexpression of ReiB in transgenic mice does not affect I kappa B α levels: differential regulation of RelA and RelB by the inhibitor protein, Oncogene 1996, 12:445-449
40. Kuikarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KG, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death, Proc Natl Acad Sci USA 1993, 90:770-774
41. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease, Nature 1992, 359:693-699